Skip to main content

Articles

Page 89 of 108

  1. Deficiencies in cellular responses to DNA damage can predispose to cancer. Ionizing radiation can cause cluster damage and double-strand breaks (DSBs) that pose problems for cellular repair processes. Three ge...

    Authors: Jonine L Bernstein, Bryan Langholz, Robert W Haile, Leslie Bernstein, Duncan C Thomas, Marilyn Stovall, Kathleen E Malone, Charles F Lynch, Jørgen H Olsen, Hoda Anton-Culver, Roy E Shore, John D Boice Jr, Gertrud S Berkowitz, Richard A Gatti, Susan L Teitelbaum, Susan A Smith…
    Citation: Breast Cancer Research 2004 6:R199
  2. Hypoxia-inducible factor 1 alpha (hif-1α) furnishes tumor cells with the means of adapting to stress parameters like tumor hypoxia and promotes critical steps in tumor progression and aggressiveness. We invest...

    Authors: Günther Gruber, Richard H Greiner, Ruslan Hlushchuk, Daniel M Aebersold, Hans J Altermatt, Gilles Berclaz and Valentin Djonov
    Citation: Breast Cancer Research 2004 6:R191
  3. The CCCTC-binding factor (CTCF), known as a versatile transcription factor and chromatin insulator and to be involved in X inactivation, has also been suggested to be a tumour suppressor on 16q. We investigate...

    Authors: Xiao-Lei Zhou, Barbro Werelius and Annika Lindblom
    Citation: Breast Cancer Research 2004 6:R187
  4. We have shown previously that whilst overexpression of HER1, 2 and 3 is associated with poor prognosis in breast cancer, HER4 is associated with a good prognosis. Cell proliferation is a key component of aggre...

    Authors: Sian M Tovey, Caroline J Witton, John MS Bartlett, Peter D Stanton, Jonathan R Reeves and Timothy G Cooke
    Citation: Breast Cancer Research 2004 6:R246
  5. Receptor-mediated estrogen activation participates in the development and progression of breast cancer. Estrogen receptor (ER)-α polymorphism has been found to be associated with breast cancer and clinical fea...

    Authors: Wei-Chiang Hsiao, Kung-Chia Young, Shoei-Loong Lin and Pin-Wen Lin
    Citation: Breast Cancer Research 2004 6:R180
  6. In order to study metastatic disease, we employed the use of two related polyomavirus middle T transgenic mouse tumor transplant models of mammary carcinoma (termed Met and Db) that display significant differe...

    Authors: Katayoun Alavi Jessen, Stephenie Y Liu, Clifford G Tepper, Juliana Karrim, Erik T McGoldrick, Andrea Rosner, Robert J Munn, Lawrence JT Young, Alexander D Borowsky, Robert D Cardiff and Jeffrey P Gregg
    Citation: Breast Cancer Research 2004 6:R157
  7. Isoflavones are hypothesized to protect against breast cancer, but it is not clear whether they act as oestrogens or anti-oestrogens in breast tissue. Our aim was to determine the effects of taking a red clove...

    Authors: Charlotte Atkinson, Ruth ML Warren, Evis Sala, Mitch Dowsett, Alison M Dunning, Catherine S Healey, Shirley Runswick, Nicholas E Day and Sheila A Bingham
    Citation: Breast Cancer Research 2004 6:R170
  8. Invasive lobular carcinoma (ILC) comprises approximately 10% of breast cancers and appears to have a distinct biology. Because it is less common than infiltrating ductal carcinoma (IDC), few data have been rep...

    Authors: Grazia Arpino, Valerie J Bardou, Gary M Clark and Richard M Elledge
    Citation: Breast Cancer Research 2004 6:R149
  9. So far there have been no reports on the expression pattern of DAX-1 (dosage-sensitive sex reversal, adrenal hypoplasia critical region, on chromosome X, gene 1) in human breast cells and its relationship to the ...

    Authors: Isabel Conde, Juan M Alfaro, Benito Fraile, Antonio Ruíz, Ricardo Paniagua and Maria I Arenas
    Citation: Breast Cancer Research 2004 6:R140
  10. Early-stage cancers have long been considered to be less aggressive than late-stage cancers because it is assumed that they have accumulated fewer of the mutations that are required for full metastatic potenti...

    Authors: Pepper Schedin and Anthony Elias
    Citation: Breast Cancer Research 2004 6:93
  11. The developmental preparation of the mammary gland for milk production that occurs during pregnancy is followed by an equally dramatic process of involution as the gland returns to its prepregnancy state. Two ...

    Authors: Stephen R Master and Lewis A Chodosh
    Citation: Breast Cancer Research 2004 6:89
  12. The transforming growth factor-β (TGF-β) signaling pathway functions to prevent tumorigenesis, and loss of sensitivity to TGF-β-mediated cell cycle arrest is nearly ubiquitous among human cancers. Our previous...

    Authors: Kimberly A Brown, Richard L Roberts, Carlos L Arteaga and Brian K Law
    Citation: Breast Cancer Research 2004 6:R130
  13. The San Antonio Breast Cancer Symposium is the largest annual meeting devoted solely to breast cancer research. The late William L McGuire's vision for this meeting was to stimulate 'translational research', m...

    Authors: Adrian V Lee, Gary Chamness and Steffi Oesterreich
    Citation: Breast Cancer Research 2004 6:E10
  14. The normal duct and lobular system of the mammary gland is lined with luminal and myoepithelial cell types. Although evidence suggests that myoepithelial cells might suppress tumor growth, invasion and angioge...

    Authors: Viviana Bumaschny, Alejandro Urtreger, Miriam Diament, Martín Krasnapolski, Gabriel Fiszman, Slobodanka Klein and Elisa Bal de Kier Joffé
    Citation: Breast Cancer Research 2004 6:R116
  15. Inflammatory breast cancer (IBC) is the most lethal form of locally advanced breast cancer. We found concordant and consistent alterations of two genes in 90% of IBC tumors when compared with stage-matched non...

    Authors: Celina G Kleer, Yanhong Zhang, Quintin Pan, Gary Gallagher, Mei Wu, Zhi-Fen Wu and Sofia D Merajver
    Citation: Breast Cancer Research 2003 6:R110
  16. In order to gain a better understanding of the molecular processes that underlie apoptosis and tissue regression in mammary gland, we undertook a large-scale analysis of transcriptional changes during the mous...

    Authors: Richard WE Clarkson, Matthew T Wayland, Jennifer Lee, Tom Freeman and Christine J Watson
    Citation: Breast Cancer Research 2003 6:R92
  17. Involution of the mammary gland is a complex process of controlled apoptosis and tissue remodelling. The aim of the project was to identify genes that are specifically involved in this process.

    Authors: Torsten Stein, Joanna S Morris, Claire R Davies, Stephen J Weber-Hall, Marie-Anne Duffy, Victoria J Heath, Alexandra K Bell, Roderick K Ferrier, Gavin P Sandilands and Barry A Gusterson
    Citation: Breast Cancer Research 2003 6:R75
  18. This American Association for Cancer Research Special Conference brought together scientists with diverse expertise to address issues related to use of appropriate epidemiological, statistical, and laboratory ...

    Authors: David G Cox
    Citation: Breast Cancer Research 2003 6:E9
  19. The oncoprotective role of food-derived polyphenol antioxidants has been described but the implicated mechanisms are not yet clear. In addition to polyphenols, phenolic acids, found at high concentrations in a...

    Authors: Marilena Kampa, Vassilia-Ismini Alexaki, George Notas, Artemissia-Phoebe Nifli, Anastassia Nistikaki, Anastassia Hatzoglou, Efstathia Bakogeorgou, Elena Kouimtzoglou, George Blekas, Dimitrios Boskou, Achille Gravanis and Elias Castanas
    Citation: Breast Cancer Research 2003 6:R63
  20. The aim of the present study was to identify the relationships between the uptake of radiotracers – namely pentavalent dimercaptosuccinic acid [(V)DMSA] and sestamibi (MIBI) – and the following parameters in p...

    Authors: Vassilios J Papantoniou, Michael A Souvatzoglou, Varvara J Valotassiou, Androniki N Louvrou, Constantina Ambela, John Koutsikos, Dimitrios Lazaris, Julie K Christodoulidou, Maria G Sotiropoulou, Maria J Melissinou, Aris Perperoglou, Spyridon Tsiouris and Cherry J Zerva
    Citation: Breast Cancer Research 2003 6:R56
  21. The expression of the oestrogen receptor (ER) is one of the more important clinical parameters of breast cancer. However, the relationship between the ER and its ligand, oestradiol, and the enzymes that synthe...

    Authors: Noriko Yoshimura, Nobuhiro Harada, Ida Bukholm, Rolf Kåresen, Anne-Lise Børresen-Dale and Vessela N Kristensen
    Citation: Breast Cancer Research 2003 6:R46
  22. The aim of the present study was to analyze the relationship between the expression of vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF) in breast cancer cells and the corresp...

    Authors: Anna Maria Granato, Oriana Nanni, Fabio Falcini, Secondo Folli, Gabriella Mosconi, Franca De Paola, Laura Medri, Dino Amadori and Annalisa Volpi
    Citation: Breast Cancer Research 2003 6:R38
  23. The recent meeting 'Advances in Breast Cancer Research – Genetics, Biology, and Clinical Implications' was an American Association for Cancer Research (AACR) Special Conference in Cancer Research, for which th...

    Authors: Alana L Welm
    Citation: Breast Cancer Research 2003 6:E6
  24. Women who have undergone a full-term pregnancy before the age of 20 have one-half the risk of developing breast cancer compared with women who have never gone through a full-term pregnancy. This protective eff...

    Authors: Lakshmanaswamy Rajkumar, Raphael C Guzman, Jason Yang, Gudmundur Thordarson, Frank Talamantes and Satyabrata Nandi
    Citation: Breast Cancer Research 2003 6:R31
  25. Many laboratories are currently evaluating the usefulness of determination of HER2, p53, and Ki67 proliferation indices using immunohistochemical techniques in cancer. Although the available studies suggest th...

    Authors: Hiroko Yamashita, Mariko Nishio, Tatsuya Toyama, Hiroshi Sugiura, Zhenhuan Zhang, Shunzo Kobayashi and Hirotaka Iwase
    Citation: Breast Cancer Research 2003 6:R24
  26. The androgen-regulated proteins prostate-specific antigen (PSA) and prostate-specific acid phosphatase (PSAP) are present in high concentrations in normal prostate and prostatic cancer and are considered to be...

    Authors: Noman Kidwai, Yun Gong, Xiaoping Sun, Charuhas G Deshpande, Anjana V Yeldandi, M Sambasiva Rao and Sunil Badve
    Citation: Breast Cancer Research 2003 6:R18
  27. Metastasis in breast cancer significantly increases morbidity and mortality. The 5-year survival rate reduces from 90% for localised disease to about 20% once metastasis has taken place. The phosphoinositide 3...

    Authors: Noan-Minh Chau and Margaret Ashcroft
    Citation: Breast Cancer Research 2003 6:55
  28. Rodent models for breast cancer have for many decades provided unparalleled insights into cellular and molecular aspects of neoplastic transformation and tumorigenesis. Despite recent improvements in the fidel...

    Authors: Kay-Uwe Wagner
    Citation: Breast Cancer Research 2003 6:31
  29. The four-day biennial 8th Nottingham Breast Cancer Conference held at the East Midlands Conference Centre, University of Nottingham, UK (16–19 September 2003) once again proved to be a successful event. Recent...

    Authors: Jane L Limer, Alicia T Parkes, Alison Waterworth, Claire E Murphy, Cathy R Tait and Caroline J Witton
    Citation: Breast Cancer Research 2003 6:E1
  30. The prognostic significance of germline mutations in BRCA1 and BRCA2 in women with breast cancer remains unclear. A combined analysis was performed to address this uncertainty.

    Authors: Mark E Robson, Pierre O Chappuis, Jaya Satagopan, Nora Wong, Jeff Boyd, John R Goffin, Clifford Hudis, David Roberge, Larry Norton, Louis R Bégin, Kenneth Offit and William D Foulkes
    Citation: Breast Cancer Research 2003 6:R8
  31. The presence and distribution of interleukin-2 (IL-2) and its receptor complex (Rα, Rβ, Rγ) were studied in 52 women who were clinically and histopathologically diagnosed with breast tumours (17 in situ and 35 in...

    Authors: Ignacio García-Tuñón, Mónica Ricote, Antonio Ruiz, Benito Fraile, Ricardo Paniagua and Mar Royuela
    Citation: Breast Cancer Research 2003 6:R1

Annual Journal Metrics

  • 2022 Citation Impact
    7.4 - 2-year Impact Factor
    7.4 - 5-year Impact Factor
    1.764 - SNIP (Source Normalized Impact per Paper)
    2.408 - SJR (SCImago Journal Rank)

    2023 Speed
    20 days submission to first editorial decision for all manuscripts (Median)
    129 days submission to accept (Median)

    2023 Usage 
    2,432,781 downloads
    1,561 Altmetric mentions